The tweet was deleted by the author.
But we saved everything 🙂.
Sujal Patel, Co-Founder and CEO of Nautilus Biotechnology, recently sat down with Nasdaq's Amplify Spotlight series to discuss the company's innovative approach to biomedicine.
During the interview, Patel outlined plans to disrupt the field with the Nautilus Proteome Analysis Platform, a technology aimed at transforming how proteins are studied and analyzed. This platform promises to offer deeper insights into proteomic data, potentially revolutionizing medical research and applications. Patel emphasized the platform's potential to significantly impact the future of healthcare by providing unprecedented access to proteome-level information.